RDY
Dr. Reddy'S Laboratories·NYSE
--
--(--)
--
--(--)
3.94 / 10
Netural
Capital flow assessment yields 7.88/10, denoting robust fund flow characteristics. Strengths in overall, block, small, large, and extra-large trends confront pressures from medium patterns, resulting in a positive liquidity outlook. Analyst sentiment reflects overwhelmingly bullish consensus with strong conviction, as indicated by a 100% Strong Buy rating from one analytical report.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-06-05
InstitutionHSBC
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of RDY?
- RDY holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.94/10 (Netural).
